Palvella Therapeutics (PVLA) EBITDA Margin Growth (3y) (2017 - 2024)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -40,178.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 530.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -932.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 7,003.00 |
| 10 | Palvella Therapeutics | 1.47 Bn | 1.21 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | -512,261.00 |
| Sep 30, 2023 | 40,603.00 |
| Jun 30, 2023 | 6,383.00 |
| Mar 31, 2023 | -66,849.00 |
| Sep 30, 2022 | -380,894.00 |
| Jun 30, 2022 | -7,483.00 |
| Mar 31, 2022 | 6,497.00 |
| Dec 31, 2021 | 174,747.00 |
| Sep 30, 2021 | -50,098.00 |
| Jun 30, 2021 | -63,592.00 |
| Mar 31, 2021 | 21,232.00 |
| Dec 31, 2020 | -77,034.00 |
| Sep 30, 2020 | -28,657.00 |
| Jun 30, 2020 | 53,633.00 |
| Mar 31, 2020 | 57,010.00 |
| Dec 31, 2019 | 16,721.00 |
| Sep 30, 2019 | 78,315.00 |
| Jun 30, 2019 | 30,746.00 |
| Mar 31, 2019 | 24,113.00 |
| Dec 31, 2018 | -254,125.00 |
| Sep 30, 2018 | 85,632.00 |
| Jun 30, 2018 | 223,299.00 |
| Mar 31, 2018 | 146,016.00 |
| Sep 30, 2017 | 964,298.00 |
| Jun 30, 2017 | -18,219.00 |